Experience

Davis Polk is advising the financial adviser to Microchip Technology Incorporated in connection with Microchip’s privately negotiated exchanges of $615 million aggregate principal amount of…

Davis Polk advised the joint book-running managers in connection with a Rule 144A offering by Enphase Energy, Inc. of $320 million aggregate principal amount of its 0.25% convertible senior…

Davis Polk advised several underwriters in connection with an SEC-registered offering of $500 million aggregate principal amount of 2.375% notes due 2030 and $300 million aggregate…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by NanoString Technologies, Inc. of $230 million aggregate principal amount of its 2.625% convertible…

Davis Polk advised the underwriters, in connection with a $2.2 billion dual-listed U.S. and Canadian initial public offering of  75,000,000 subordinate voting shares ($1.425 billion)…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by NuVasive, Inc. of $450 million aggregate principal amount of its 0.375% convertible senior notes due…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Bandwidth Inc. of an aggregate principal amount of $400 million of its 0.25% convertible senior…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Revance Therapeutics, Inc. of $287.5 million aggregate principal amount of its 1.75% convertible senior…

Davis Polk advised SMART Global Holdings, Inc. in connection with a Rule 144A offering of $250 million aggregate principal amount of its 2.25% convertible senior notes due 2026. Davis Polk…

Davis Polk advised the joint book-running managers and representatives of the initial purchasers on a Rule 144A offering by Integra LifeSciences Holdings Corporation of $575 million…